Skip to main content

Faculty Research

Physician scientists in the Department of Urology at IU School of Medicine are contributing substantially to the advancement of patient care in urologic cancer, pediatric reconstruction, stone treatments and other areas.

Retroperitoneal lymph node dissection

Retroperitoneal lymph node dissection (RPLND) is a highly specialized surgical procedure used to remove lymph nodes surrounding the aorta and vena cava — structures located behind the peritoneal cavity that houses the small and large intestines. The foundational understanding and technique for RPLND were developed at Indiana University School of Medicine in the mid-1960s, establishing IU as the birthplace of modern testicular cancer surgery. Over the past 60 years, these techniques have been continually refined, dramatically reducing morbidity and complications while achieving outstanding patient outcomes. IU School of Medicine also pioneered the nerve-sparing RPLND approach to preserve fertility, contributing to decades of unparalleled expertise and leadership in this procedure.

Holmium laser enucleation of the prostate

Holmium laser enucleation of the prostate (HoLEP) is a minimally invasive procedure that removes excess prostate tissue to relieve obstruction and restore more normal urinary function. Our center was the first to introduce this technology to the United States and continues to maintain one of the nation’s largest and most experienced HoLEP programs. Because the procedure is performed entirely through the urethra without any external incisions, patients benefit from a rapid recovery, durable symptom relief and excellent long-term outcomes.

Indiana Pouch

The Indiana Pouch was developed at IU School of Medicine in the late 1980s through a collaborative effort between our pediatric and adult urology teams. This innovative form of bladder substitution can be used in both children and adults for a variety of conditions, including spina bifida, severe stricture disease and bladder cancer. The procedure repurposes a segment of the small and large intestine to create an internal reservoir that safely stores urine, allowing patients to empty the pouch through a small abdominal stoma. By avoiding the need for an external urine bag, the Indiana Pouch offers improved continence, discretion and overall quality of life.

High-intensity focused ultrasound

High-intensity focused ultrasound (HIFU) was originally studied and developed here at IU School of Medicine, where early research explored its use for benign prostatic enlargement before its evolution into a treatment option for localized prostate cancer. This incisionless therapy precisely targets and destroys cancerous tissue while preserving surrounding structures. As a result, HIFU offers excellent control of localized disease with a favorable side-effect profile, often maintaining urinary and sexual quality of life better than many traditional treatment approaches.

Congenital adrenal hyperplasia

Congenital adrenal hyperplasia (CAH) is a group of inherited disorders in which the adrenal glands cannot produce key hormones — most commonly cortisol — due to enzyme deficiencies affecting about 1 in 10,000 live births in the U.S. and Europe. As a result, the body may overproduce androgens, leading to symptoms such as atypical genital development, rapid childhood growth or hormonal imbalances. Our pediatric urologists lead a comprehensive care center of excellence in the management of these patients.  This requires a dedicated multi-disciplinary team to address pediatric urologic surgical issues, endocrinology management, psychologic and genetic issues.

High Intensity Focused Ultrasound

Department of Urology researchers developed a treatment for prostate cancer with technology pioneered at IU School of Medicine in the 1970’s. The method was approved by the FDA in 2015.

Single Slice Equation

Urology researchers created the single slice equation as a way to predict how much damage might be done to a kidney when treating kidney cancer in patients.

Clinical Trials

The Department of Urology participates in clinical trials that explore new therapeutic treatments for urologic problems. Participating in clinical trials offers patients the opportunity to receive new treatments while contributing to the future of health care. Patients who participate in clinical trials receive especially close, personalized care by a specialized team of urologists and clinical research coordinators. Participation in these studies may have additional benefits of free medication, study related tests, x-rays and exams or even financial compensation.

Learn more